Skip to main content

Articles

Page 10 of 16

  1. The coronavirus disease (COVID-19) pandemic has placed enormous pressures on the Canadian healthcare system. Patients are expected to stay home in order to contain the spread of the virus, but understandably h...

    Authors: Ali Elbeddini and Aniko Yeats
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:23
  2. The affordability of essential medicines is a challenge in achieving Universal Health Coverage (UHC). One of The Lancet Commission’s recommendations on financing of essential medicines is to ensure governments...

    Authors: Velisha Ann Perumal-Pillay and Fatima Suleman
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:17
  3. Amid COVID-19 Crisis, reporting adverse drug reactions (ADRs) and medical device incidents (MDIs) to Health Canada or health authorities in every country is crucial for monitoring medication safety and improving ...

    Authors: Ali Elbeddini, Aniko Yeats and Stephanie Lee
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:18

    The Correction to this article has been published in Journal of Pharmaceutical Policy and Practice 2020 13:30

  4. This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinica...

    Authors: Vesa Halimi, Armond Daci, Simona Stojanovska, Irina Panovska-Stavridis, Milena Stevanovic, Venko Filipce and Aleksandra Grozdanova
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:16
  5. There is plenty of evidence to support that women leaders are needed in the health and pharmaceutical sectors, although most of the leadership positions in global health are predominantly occupied by men. This...

    Authors: Nadia Bukhari, Mehr Manzoor, Huma Rasheed, Bismah Nayyer, Madeeha Malik and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:15
  6. The use of quality injectable oxytocin effectively prevents and treats postpartum hemorrhage, the leading cause of maternal death worldwide. In low- and middle-income countries (LMICs), characteristics of oxyt...

    Authors: Peter Lambert, Michelle P McIntosh, Mariana Widmer, Lawrence Evans, Megan Rauscher, Rutendo Kuwana, Fiona Theunissen, Beth Yeager and Helen Petach
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:14
  7. The world currently faces unprecedented health challenges as COVID-19 poses a huge threat to health systems, economies and societies as we know it. The events of the current COVID-19 pandemic have further emph...

    Authors: Amy Hai Yan Chan, Victoria Rutter, Diane Ashiru-Oredope, Chloe Tuck and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:13
  8. Poor job satisfaction has been associated with less productivity and high staff turnover. Various factors are thought to contribute for job dissatisfaction among pharmacy professionals and very limited studies...

    Authors: Yohanes Ayele, Behailu Hawulte, Tilayie Feto, G. Vijai Basker and Yadeta Dessie Bacha
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:11
  9. Substandard and falsified medicines, mainly prevalent in low and middle-income countries (LMICs), cause avoidable morbidity and mortality, and put at stake the performance of health systems. They may be preven...

    Authors: B. Schiavetti, E. Wynendaele, V. Melotte, J. Van der Elst, B. De Spiegeleer and R. Ravinetto
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:9
  10. Antimicrobial resistance (AMR) is an imminent threat to modern medicine. As the efficacy of treatment regimens is reduced, mortality and morbidity attributed to infectious diseases is expected to rise dramatic...

    Authors: Lyduine Nisabwe, Hirwa Brice, Marie Christine Umuhire, Olivia Gwira, Jean De Dieu Harelimana, Zephanie Nzeyimana, Osee Rurambya Sebatunzi, Emmanuel Kamanzi Rusingiza, Innocent Hahirwa and Claude Mambo Muvunyi
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:7
  11. As the lockdowns are being observed all over the globe and the national level pharmacy professionals are performing frontline roles, this editorial highlights the role of pharmacists in the COVID − 19 pandemic...

    Authors: Nadia Bukhari, Huma Rasheed, Bismah Nayyer and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:8
  12. To assess the variation in price among different brands of anticancer medicines available in hospital pharmacies at Nepalese cancer hospitals.

    Authors: Sunil Shrestha, Ramesh Sharma Poudel, Bhuvan KC, Bhupendra Kumar Poudel, Binaya Sapkota, Sabina Sharma and Anil Khadka
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:6
  13. There has been increased demand for greater public accountability and transparency of private sector-led global health partnership programs. This study critically reviews and pilot tests the World Health Organ...

    Authors: Chukwuemeka A. Umeh, Peter C. Rockers, Richard Laing, Ovi Wagh and Veronika J. Wirtz
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:5
  14. Pharmaceutical companies actively advertise their branded antibiotics, which influence their sales at community pharmacies. The major proportion of out of pocket health spending is on medicine; and affordabili...

    Authors: Pramesh Koju, Stéphane P. Rousseau, Marc Van der Putten, Archana Shrestha and Rajeev Shrestha
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:4
  15. Authors: Salman Mehmood, Syed Muhammad Farid Hasan, Chinara Maratovna Razzakova, Liliya Eugenevna Ziganshina, Azjargal Ganbat, Tsetsegmaa Sanjjav, Bruce Sunderland, Gantuya Dorj, Gereltuya Dorj, Satibi Satibi, M. Rifqi Rokhman, Hardika Aditama, Ika Kartini, Rini Ambarsari, Fajar Pramesti, Peng Yeow Loh…
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13(Suppl 1):3

    This article is part of a Supplement: Volume 13 Supplement 1

  16. Understanding why adults resort to herbal medicine can help in planning interventions aimed at increasing awareness regarding herbal use. This study sought to investigate the prevalence and to determine factor...

    Authors: Faris El-Dahiyat, Mohamed Rashrash, Sawsan Abuhamdah, Rana Abu Farha and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:2
  17. In recent years, there has been increasing pressure on public health systems in high-income countries due to high medicines prices, one of the underlying causes of which are the market monopolies granted to ph...

    Authors: Yuanqiong Hu, Dimitri Eynikel, Pascale Boulet and Gaelle Krikorian
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:1
  18. HIV in Pakistan is concentrated to people who inject drugs (PWID) and easy accessibility of narcotics to this population cannot be disregarded as a risk factor of growing encumbrance of AIDS in the country. Al...

    Authors: Tauqeer Hussain Mallhi, Yusra Habib Khan, Amjad Khan, Nasser Hadal Alotaibi, Abdulaziz Ibrahim Alzarea and Furqan Khurshid Hashmi
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:37
  19. Following publication of the original article [1], we have been notified of a few errors in the figures:

    Authors: Cristiane Mota Soares, Beatriz Nascimento, Luisa Arueira Chaves, Rondineli Mendes Silva, Maria Auxiliadora Oliveira and Vera Lucia Luiza
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:35

    The original article was published in Journal of Pharmaceutical Policy and Practice 2019 12:33

  20. Glycated hemoglobin (HbA1c) is accepted as the most reliable marker for assessing chronic glycemia. The present study aimed to investigate glycemic control in cardiovascular outcome trials (CVOTs) performed by...

    Authors: Rumiko Shimazawa and Masayuki Ikeda
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:30
  21. Medicines wastage is one of the challenges of health supply chain management in developing countries including Ethiopia. However, there is lack of objective evidence on the detailed underlying causes of medici...

    Authors: Esayas Tadesse Gebremariam, Dawit Teshome Gebregeorgise and Teferi Gedif Fenta
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:29
  22. Infertility is a major challenge for couples globally. Due to low income levels and the high cost of other assisted reproductive techniques, pharmacotherapy remain the major first line treatment option for inf...

    Authors: Stephen Mensah Arhin, Kwesi Boadu Mensah, Evans Agbeno, Vitus Sambo Badii and Charles Ansah
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:28
  23. The Kuwaiti drug regulatory authority (DRA) lack a structured classification system for the assessment of imported herbal medicines (HMs), which leads to ambiguity in the registration process. This study aimed...

    Authors: Azhar H. Alostad, Douglas T. Steinke and Ellen I. Schafheutle
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:32
  24. Quality issues in pharmaceuticals are identified as a huge global and public health problem, especially with reference to low- and middle-income countries like Pakistan. The 2011 “Fake Drug Crisis” acted as a ...

    Authors: Huma Rasheed, Ludwig Hoellein, Khalid Saeed Bukhari and Ulrike Holzgrabe
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:23
  25. Two billion people worldwide, predominantly in low- and middle-income countries, cannot consistently access required essential medications, thus affecting their ability to attain optimal health outcomes. Acces...

    Authors: Marcia McLean, Jillian Clare Kohler and Danny Edwards
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:26
  26. To identify and analyze the criteria, approaches, and conceptual frameworks, used for national/international priority setting.

    Authors: Alberto Frutos Pérez-Surio, Mercedes Gimeno-Gracia, Ma. Aránzazu Alcácera López, Ma. Asunción Sagredo Samanes, Ma. del Puerto Pardo Jario and Ma. del Tránsito Salvador Gómez
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:21
  27. To describe changes in the private market for selected originators, branded generics (‘similares’), and generic products during the 10 years following passage of the Brazilian Generics Law.

    Authors: Andréa Dâmaso Bertoldi, Anita K. Wagner, Isabel Cristina Martins Emmerick, Luisa Arueira Chaves, Peter Stephens and Dennis Ross-Degnan
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:18
  28. Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, although serious adverse effects such as agranulocytosis and cardiomyopathy limit its use. In July 2015, Australian regulati...

    Authors: Bethany Wilson, Sara S. McMillan and Amanda J. Wheeler
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:19
  29. The rational use of medicine improves patient’s quality of life. Excessive and inappropriate prescriptions result in severe consequences. The study of drug use patterns and prescription errors is necessary to ...

    Authors: Rajeev Shrestha and Srijana Prajapati
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:16
  30. As part of the initiatives to increase price transparency for consumers, pharmaceutical industry in Malaysia have been encouraged to declare the wholesale and recommended retail prices (RRP) of medicines to th...

    Authors: Nur Sufiza Ahmad, Ernieda Hatah and Mohd Makmor-Bakry
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:15
  31. Pharmaceutical pricing has only recently gained space in mainstream health science literature.

    Authors: Maria Angelica Borges dos Santos, Leticia Lucia dos Santos Dias, Cláudia Du Bocage Santos Pinto, Rondineli Mendes da Silva and Claudia Garcia Serpa Osorio-de-Castro
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:24
  32. Methemoglobinemia (MetHb) being a rare cause of cyanosis is generally not considered in its differential diagnosis. Methemoglobinemia is an abnormal Hb produced physiologically by auto-oxidation. If this proce...

    Authors: Najia Mahmood, Mutti Ullah Khan, Ihtisham U. L. Haq, Farhat Afshan Jelani and Aayesha Tariq
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:22
  33. Questionnaires capture patient perspectives succinctly and at relatively low cost, making them a popular data collection tool for health researchers. However, questionnaire data can be affected by response err...

    Authors: Marissa Ayano Mes, Amy Hai Yan Chan, Vari Wileman, Caroline Brigitte Katzer, Melissa Goodbourn, Steven Towndrow, Stephanie Jane Caroline Taylor and Rob Horne
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:17
  34. Few low and middle-income countries (LMIC) have fully operational pharmacovigilance structures, systems and legal framework to collect and collate safety data and evaluate the risks and benefits by active and ...

    Authors: Onome T. Abiri and Wiltshire C. N. Johnson
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:13
  35. Improving access to medicines is a major healthcare challenge for low-income countries because the problem traverses health systems, society and multiple stakeholders. The Annapurna region of Nepal provides a ...

    Authors: Bhuvan K.C., Susan Heydon and Pauline Norris
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:11
  36. Countries all around the globe are working to establish robust pharmacovigilance systems. Whereas the majority of the developed countries have established well-organized pharmacovigilance systems, the developi...

    Authors: Rabia Hussain and Mohamed Azmi Hassali
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:14
  37. Existing literature does not provide enough information on evaluation of factors associated with pre-dialysis controlled hypertension among euvolemic hemodialysis (HD) patients. We conducted a study to evaluat...

    Authors: Amjad Khan, Amer Hayat Khan, Azreen Syazril Adnan, Syed Azhar Syed Sulaiman, Saima Mushtaq, Nafees Ahmad and Irfanullah Khan
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:10
  38. Universal Health Coverage (UHC) in Indonesia is planned to be fully implemented in 2019 through the National Health Insurance (NHI) launched in January 2014. However, limited financial resources cause health c...

    Authors: Endang Yuniarti, Yayi Suryo Prabandari, Erna Kristin and Sri Suryawati
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:7
  39. Expired or unused medicines are potentially toxic substances that should be managed effectively to avoid accumulation of potentially toxic pharmaceuticals in the environment. In Nigeria, there is currently lim...

    Authors: Iweh Michael, Brian Ogbonna, Nduka Sunday, Maureen Anetoh and Okonta Matthew
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:12
  40. In Kuwait, the government is planning to improve the specifications for purchase of medicine and to improve the tendering system intending to slow the growth of the expenditure for medicine and to improve the ...

    Authors: Ali Hadi Abdullah, Anke-Peggy Holtorf, Maryam Al-Hussaini, Jacinthe Lemay, Maryam Alowayesh and Zoltán Kaló
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:9

Annual Journal Metrics

  • 2022 Citation Impact
    4.2 - 2-year Impact Factor
    1.266 - SNIP (Source Normalized Impact per Paper)
    0.574 - SJR (SCImago Journal Rank)

    2023 Speed
    28 days submission to first editorial decision for all manuscripts (Median)
    104 days submission to accept (Median)

    2023 Usage
    852,978 downloads
    963 Altmetric mentions